‘Super Aspirin’ could net firm €500m bonanza

A CORK company has developed a side-effect-free aspirin which is expected to generate millions of euro over 10 years.

It is in early-stage talks with a number of multinational pharmaceutical companies based in Cork regarding the development of the drug it has named Super Aspirin.

It expects the product to be on sale in the next two years, pending regulatory approval and sales are anticipated to hit €500 million by 2020.